Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism M&A Podcasts Private Cos. Private Equity Restructuring Scoops & Exclusives SPACs

Page 13

Private Equity

Excellere Looks to Exit Ag Chems Maker SePro

By Tom Terrarosa
|
Published: June 9th, 2022
The private equity firm has engaged Raymond James and Piper Sandler to market its stake in the Indiana-based chemicals company with around $40 million of Ebitda.
Private Equity

SK Taps Guggenheim, Moelis to Test Market for Tilley

By Tom Terrarosa
|
Published: June 9th, 2022
The firm has hired advisers for a future auction of Tilley less than two years after investing in the platform, hoping to capitalize on its rapidly expanded profits and revenue.
M&A

Exit Ramp: Sponsors May Call on SonicWall

By Chris Nolter
|
Published: June 8th, 2022
As cybersecurity peers Barracuda Networks and WatchGuard strike deals, Francisco Partners- and Elliott Management-backed SonicWall could come to market as well.
M&A

Cincinnati Bell Sends Books on Tech Services Unit

By Chris Nolter
|
Published: June 8th, 2022
CBTS could attract privately held peers such as Centerbridge portfolio company Ahead or BC Partners-backed Presidio, sources suggest, though a final price tag is still up for debate.
Activism

Kohl’s Retains Goldman, Rejects Bids

By Ronald Orol
|
Published: February 4th, 2022
The activist-targeted department store chain rejects expressions of interest while noting it has retained Goldman Sachs — first reported last month in The Deal — to engage with interested parties.
M&A

CI Capital Sells Epiphany Dermatology

By Armie Margaret Lee
|
Published: February 3rd, 2022
The Deal reported in October that the PE firm was exploring a sale of the Austin, Texas-based dermatology company.
 Company
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
[email protected]
© 2025 The Deal.

Part of the Delinian Group. Terms of Use, Commercial Terms & Conditions, Privacy Policy, Accessibility, Modern Slavery Act